Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancers.

Autor: Hilbers FS; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands., Poncet C; European Organization for Research and Treatment of Cancer- EORTC Headquarters, Brussels, Belgium., Tryfonidis K; European Organization for Research and Treatment of Cancer- EORTC Headquarters, Brussels, Belgium., Viale G; Department of Pathology, IEO European Institute of Oncology IRCCS, Milan, Italy., Delaloge S; Department of Cancer Medicine, Institut Gustav Roussy, Villejuif, Paris, France., Pierga JY; Department of Medical Oncology, Institut Curie, Sorbonne Paris Cite, Paris, France., Brain EGC; Department of Medical Oncology, Institut Curie, Sorbonne Paris Cite, Paris, France., Rubio IT; Breast Surgical Oncology Unit, Clinica Universidad de Navarra, Madrid, Spain., Thompson AM; Department of Surgery, Baylor College of Medicine, Houston, TX, USA., Rutgers EJT; Department of Surgery, Netherlands Cancer Institute, Amsterdam, Netherlands., Piccart MJ; Department of Medical Oncology, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium., van 't Veer LJ; Department of Laboratory Medicine, University of California, San Francisco, CA, USA., Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. fatimacardoso@fundacaochampaliamaud.pt.

Publikováno v: NPJ breast cancer [NPJ Breast Cancer] 2024 Nov 02; Vol. 10 (1), pp. 97. Date of Electronic Publication: 2024 Nov 02.

Leveraging transcriptomics for precision diagnosis: Lessons learned from cancer and sepsis.

Autor: Tsakiroglou, Maria, Evans, Anthony, Pirmohamed, Munir

Publikováno v: Frontiers in Genetics; 3/10/2023, Vol. 14, p1-17, 17p

Oncobiology and treatment of breast cancer in young women.

Autor: Kumar R; Cancer Research Institute, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, India. rakeshkumar@srhu.edu.in.; Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Trivandrum, India. rakeshkumar@srhu.edu.in.; Department of Medicine, Division of Hematology and Oncology, Rutgers New Jersey Medical School, Newark, NJ, USA. rakeshkumar@srhu.edu.in.; Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA. rakeshkumar@srhu.edu.in., Abreu C; Department of Medical Oncology, Hospital de Santa Maria- Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal., Toi M; Graduate School of Medicine, Kyoto University, Kyoto, Japan., Saini S; Cancer Research Institute, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, India., Casimiro S; Instituto de Medicina Molecular-João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal., Arora A; Cancer Research Institute, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, India., Paul AM; Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Trivandrum, India., Velaga R; Graduate School of Medicine, Kyoto University, Kyoto, Japan., Rameshwar P; Department of Medicine, Division of Hematology and Oncology, Rutgers New Jersey Medical School, Newark, NJ, USA., Lipton A; Hematology-Oncology, Department of Medicine, Penn State University School of Medicine, Hershey, PA, USA., Gupta S; Department of Medical Oncology, Tata Memorial Centre and Homi Bhabha National Institute, Mumbai, India., Costa L; Department of Medical Oncology, Hospital de Santa Maria- Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.; Instituto de Medicina Molecular-João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.

Publikováno v: Cancer metastasis reviews [Cancer Metastasis Rev] 2022 Sep; Vol. 41 (3), pp. 749-770. Date of Electronic Publication: 2022 Apr 30.